Liang‐Chih Liu
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Surgery
- Co-authors
- Tzong‐Der WayChao-Ming HungChi‐Tang HoJung‐Yie KaoHwei-Chung WangYung‐Luen YuJiayan WuShao‐Chun Wang
- Topics
- Breast Cancer Treatment Studies (11 papers)HER2/EGFR in Cancer Research (8 papers)Credit Risk and Financial Regulations (7 papers)
- Journals
- PLoS ONECancerCancer Research
- Partner nations
- TaiwanUnited StatesSingapore
In The Last Decade
Liang‐Chih Liu
76 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 556
- Cancer Research 432
- Oncology 377
- Pathology and Forensic Medicine 158
- Surgery 137
Countries citing papers authored by Liang‐Chih Liu
This map shows the geographic impact of Liang‐Chih Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang‐Chih Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang‐Chih Liu more than expected).
Fields of papers citing papers by Liang‐Chih Liu
This network shows the impact of papers produced by Liang‐Chih Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang‐Chih Liu. The network helps show where Liang‐Chih Liu may publish in the future.
Co-authorship network of co-authors of Liang‐Chih Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Liang‐Chih Liu. A scholar is included among the top collaborators of Liang‐Chih Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang‐Chih Liu. Liang‐Chih Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 17 | |
| 11 | 18 | |
| 12 | 57 | |
| 13 | 10 | |
| 14 | 9 | |
| 15 | 20 | |
| 16 | 18 | |
| 17 | The carcinoembryonic antigen as a potential prognostic marker for neuroendocrine carcinoma of the breast. | 9 |
| 18 | 12 | |
| 19 | Association between ataxia telangiectasia mutated gene polymorphisms and breast cancer in Taiwanese females. | 23 |
| 20 | 17 |
About Liang‐Chih Liu
Liang‐Chih Liu is a scholar working on Cancer Research, Oncology and Finance, having authored 83 papers that have together received 1.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), HER2/EGFR in Cancer Research (8 papers) and Credit Risk and Financial Regulations (7 papers). The work is most often cited by research in Cancer Research (432 citations), Oncology (377 citations) and Applied Microbiology and Biotechnology (25 citations). Liang‐Chih Liu has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Tzong‐Der Way, Chao-Ming Hung, Chi‐Tang Ho, Jung‐Yie Kao, Hwei-Chung Wang, Yung‐Luen Yu, Jiayan Wu, Shao‐Chun Wang, Chih‐Jung Chen and Ying-Chao Lin. Their work appears in journals such as PLoS ONE, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.